Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

BEAT - HeartBeam Inc


IEX Last Trade
2.32
0.110   4.741%

Share volume: 37,888
Last Updated: Fri 30 Aug 2024 09:59:14 PM CEST
Surgical and Medical Instrument Manufacturing : -0.56%

PREVIOUS CLOSE
CHG
CHG%

$2.21
0.11
4.98%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
54%
Profitability 48%
Dept financing 45%
Liquidity 36%
Performance 66%
Company vs Stock growth
vs
Performance
5 Days
0   0%
1 Month
-0.84%
3 Months
-16.67%
6 Months
62.07%
1 Year
10.33%
2 Year
79.39%
Key data
Stock price
$2.32
P/E Ratio 
0.00
DAY RANGE
N/A - $2.35
EPS 
$0.00
52 WEEK RANGE
$1.06 - $3.39
52 WEEK CHANGE
$0.05
MARKET CAP 
62.421 M
YIELD 
N/A
SHARES OUTSTANDING 
26.562 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/14/2024
BETA 
1.88
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$39,811
AVERAGE 30 VOLUME 
$42,352
Company detail
CEO:
Region: US
Website:
Employees: 18
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

heartbeam developed a mhealth technology that is diagnostically equivalent to a cardiologist reading a patient’s 12 lead ecg and examining the patient. it comprises a credit card size, 12 lead equivalent, ecg device and a cloud-based diagnostic expert system. studies designed by harvard medical school faculty have shown heartbeam performance to be equal or better than world class cardiologists in diagnosing a heart attack. the technology features personalized diagnostic thresholds and novel heart attack ecg markers from which the application can also help cardiologists locate a heart attack on a 3d model of the heart. heartbeam's icardiologist application utilizes artificial intelligence / machine learning to drive continuous improvements of the system's ability to provide patient analysis and improve the solution's predictive properties.

Recent news